Ifp Advisors, Inc Maxcyte, Inc. Transaction History
Ifp Advisors, Inc
- $3.28 Billion
- Q2 2025
A detailed history of Ifp Advisors, Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 56 shares of MXCT stock, worth $80. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56
Previous 34
64.71%
Holding current value
$80
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
71.1MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.91MShares$12.8 Million1.1% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$11.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.03MShares$10.1 Million0.0% of portfolio
-
Mirabella Financial Services LLP London, X06.6MShares$9.5 Million1.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$8.05 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $146M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...